Xcyte Digital Corp. (PSYF.P) | Finanzwire

Basculer en Français

8299	Companies
114942	Keywords
55348	Articles
62469	Press releases

Home
Companies
Xcyte Digital Corp.

BRIEF

published on 05/16/2024 at 15:05, 6 months 4 days ago

Xcyte Digital Corp. Introduces "Xperience" Subscription Service for Event Organizers

Event Management Event Technology Subscription Service Xcyte Digital Corp Xperience
PRESS RELEASE

published on 05/16/2024 at 15:00, 6 months 4 days ago

Xcyte Digital Corp. Releases "Xperience" Subscription Service
Xcyte announces 'Xperience', an all-in-one event technology subscription service, offering access to a global ecosystem of event technologies. The new service aims to provide cost-effective solutions for various event formats

Event Technology Subscription Service Xperience Xcyte Global Ecosystem
PRESS RELEASE

published on 12/04/2023 at 14:30, 11 months 17 days ago

Xcyte Digital Produces Second Metaverse Spectrum Business Conference and Launches Inaugural Pitch Fest
Xcyte Digital Corp. to produce the second annual Metaverse Spectrum Business Conference and Expo on December 6-7, 2023, featuring industry leaders and a Pitch Fest for AI, VR, Web3, and AR companies

Artificial Intelligence Virtual Reality Xcyte Digital Corp. Metaverse Spectrum Business Conference Pitch Fest
PRESS RELEASE

published on 11/15/2023 at 16:00, 1 year ago

Virtual Event Services Provider Xcyte Digital Begins Trading on the TSX Venture Under the Ticker XCYT
PRESS RELEASE

published on 11/10/2023 at 00:25, 1 year ago

Xcyte Digital Announces Closing of Qualifying Transaction and Concurrent Financing
PRESS RELEASE

published on 11/02/2023 at 23:10, 1 year ago

GHP Noetic Science-Psychedelic Pharma Announces TSXV Conditional Approval of Proposed Qualifying Transaction
PRESS RELEASE

published on 07/28/2023 at 22:40, 1 year 3 months ago

GHP Noetic Science-Psychedelic Pharma Inc. Provides Update on Qualifying Transaction With Xcyte Digital Corp.
PRESS RELEASE

published on 06/22/2023 at 22:35, 1 year 4 months ago

GHP Noetic Science-Psychedelic Pharma Inc. and Xcyte Digital Corp. Proposed Qualifying Transaction
PRESS RELEASE

published on 02/09/2023 at 19:00, 1 year 9 months ago

GHP Noetic Science-Psychedelic Pharma Inc. and Xcyte Digital Corp. Proposed Qualifying Transaction

Accesswire

Published on 11/21/2024 at 14:15, 22 minutes ago

neurocare Group AG Welcomes Kevin Reeder as Chief Financial Officer
Published on 11/21/2024 at 14:00, 37 minutes ago

Demotech, Inc. Assigns a Financial Stability Rating(R) of A, Exceptional, to Steadily Insurance Company
Published on 11/21/2024 at 14:00, 37 minutes ago

Montara Raises $5.4M to Help Organizations Deliver Better Data Products Faster
Published on 11/21/2024 at 14:00, 37 minutes ago

Tevir Capital LP Ltd. Updates Early Warning Reporting in Respect of VerticalScope Holdings Inc.
Published on 11/21/2024 at 14:00, 37 minutes ago

GameSquare's Stream Hatchet Publishes Q3 Report

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 14:16, 20 minutes ago

EQS-Adhoc: LM PAY S.A. Announces Third Quarter 2024 Preliminary Results and Updated Guidance
Published on 11/21/2024 at 14:15, 21 minutes ago

ZenaTech Signs Blue UAS and NDAA Compliant Supply Chain Partners to Sell to US Defense Branches and NATO Forces
Published on 11/21/2024 at 14:00, 36 minutes ago

Form 8.3 - LOYS AG: Learning Technologies Group plc
Published on 11/21/2024 at 13:15, 1 hour 21 minutes ago

NOTICE OF ANNUAL GENERAL MEETING
Published on 11/21/2024 at 12:35, 2 hours 1 minute ago

audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6

Les Echos

Published on 11/21/2024 at 06:58, 7 hours 39 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 19 hours 16 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 20 hours 52 minutes ago

MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 20 hours 52 minutes ago

Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 6 hours ago

Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo

View all LES ECHOS COMFI WIRE